| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cidara Therapeutics, Inc. | Director | Stock Option (right to buy) | 42.5K | 22 Jun 2023 | Direct | ||
| Paratek Pharmaceuticals, Inc. | Director | Common Stock | 0 | $2.20 | 21 Sep 2023 | Direct | |
| Paratek Pharmaceuticals, Inc. | Director | Stock option (right to buy) | 0 | 21 Sep 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PRTK | Paratek Pharmaceuticals, Inc. | 21 Sep 2023 | 9 | $0 | 4 | Director | 21 Sep 2023, 13:17 |
| CDTX | Cidara Therapeutics, Inc. | 22 Jun 2023 | 1 | $0 | 4 | Director | 23 Jun 2023, 17:21 |
| PRTK | Paratek Pharmaceuticals, Inc. | 21 Feb 2023 | 1 | -$13.2K | 4 | Director | 23 Feb 2023, 13:22 |
| PRTK | Paratek Pharmaceuticals, Inc. | 08 Feb 2023 | 1 | $0 | 4 | Director | 09 Feb 2023, 20:12 |
| CDTX | Cidara Therapeutics, Inc. | 22 Jun 2022 | 1 | $0 | 4 | Director | 24 Jun 2022, 17:34 |
| PRTK | Paratek Pharmaceuticals, Inc. | 16 Feb 2022 | 1 | $0 | 4 | Director | 18 Feb 2022, 16:18 |
| CDTX | Cidara Therapeutics, Inc. | 13 Sep 2021 | 1 | $14.8K | 4 | Director | 14 Sep 2021, 19:59 |
| CDTX | Cidara Therapeutics, Inc. | 23 Jun 2021 | 1 | $0 | 4 | Director | 24 Jun 2021, 18:05 |